Hookipa announces formation of Scientific Advisory Board

14-Jan-2013 - Austria

Hookipa Biotech AG announced the formation of its Scientific Advisory Board (SAB).  The SAB is chaired by Emeritus Prof. Dr. Paul-Henri Lambert (PhD), former Chief of Vaccine Research and Development for the WHO Global Program for Vaccines and Immunizations. 

The members include scientists and industrial experts:  Emeritus Prof. Dr. Stanley Plotkin (MD), Prof. Dr. Michael Mach (PhD), Dr. Arnaud Marchant (MD, PhD) and Prof. Dr. Franz Heinz (PhD).  The SAB will provide advice to the Company on a broad range of topics related to research, development, manufacturing, quality control, medical, regulatory, and commercial aspects of the Company’s Vaxwave® platform and specific vaccine targets.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances